Skip to main content
Premium Trial:

Request an Annual Quote

Van Andel Starts Translational Cancer Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Van Andel Research Institute (VARI) has started a new pediatric cancer research program that will focus on using molecular analysis and personalized medical approaches, VARI said today.

The VARI Pediatrics Cancer Translational Research Program will use genomic techniques to develop treatments for children with cancer.

The program will be led by pediatric oncologist Giselle Sholler, who currently is chair of the Neuroblastoma and Medulloblastoma Translational Research Consortium, and by co-director Craig Webb, who also is director of VARI's Program of Translational Medicine.

"This new initiative is undertaken with the best objective that I can possibly imagine: the goal of curing children with cancer," VARI Chairman and CEO David Van Andel said in a statement.

Grand Rapids, Mich.-based VARI said that the new program will enable large-scale projects using genomics and molecular analysis techniques to identify the best treatment options based on the individual tumor biology.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.